Skip to main content

Tannenbaum Renee P

In the past year, 1 open-market sale filing worth $146.1K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$146.1K
1 filing
Net
−$146.1K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Tannenbaum Renee P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ANIP Ani Pharmaceuticals Inc

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 9, 2025 (view filing)Dec 54 daysTannenbaum Renee PDirectorSSale−1.80K$81.15−$146.1K−6.7%25.2K after
May 17, 2024 (view filing)May 161 dayTannenbaum Renee PDirectorSSale−2.00K$63.87−$127.7K−9.9%18.2K after

CRDF Cardiff Oncology, Inc.

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 16, 2024 (view filing)Dec 124 daysTannenbaum Renee PDirectorPPurchase+10.0K$3.42+$34.2K+100.0%20.0K after
Sep 19, 2022 (view filing)Sep 154 daysTannenbaum Renee PDirectorPPurchase+10.0K$1.72+$17.2KNew position10.0K after2 lots

ZGNX Zogenix, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 30, 2021 (view filing)Nov 291 dayTannenbaum Renee PDirectorSSale−5.30K$11.72−$62.2K−14.0%32.6K after